Oral vs topical minoxidil, and who gets to decide

The difference between oral and topical minoxidil is not strength or convenience. It is that one of them is an approved hair-loss product you can buy off a shelf, and the other is a prescription medicine for dangerous high blood pressure that some clinicians use for hair anyway. Everything else follows from that.

This page compares the two from their approved United States labels. It contains no dose, no regimen and no comparison of "how much" — those do not belong on a website, and in the tablet's case they do not belong anywhere outside a consulting room.

The two labels, side by side

The topical product is licensed for the job. Its carton reads Active ingredient "Minoxidil 5% w/v", Purpose "Hair regrowth treatment for men", and its approved use is "to regrow hair on the top of the scalp (vertex only, see pictures on side of this carton)". The whole document is written for somebody standing in an aisle.

The tablet is a different genre. Its label is "indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs" — that is, for high blood pressure that has already resisted a stack of other medicines. And then, in the precautions, one sentence settles the whole argument: "Use of minoxidil tablets, in any formulation, to promote hair growth is not an approved indication."

That sentence does not mean a doctor may not prescribe it for hair. Off-label prescribing is legal and ordinary across medicine. It means that no regulator has assessed the tablet for this purpose, that no approved efficacy figure for it exists, and that the person taking responsibility for the decision is the prescriber rather than a manufacturer.

What the tablet's label warns about

The tablet carries a boxed warning, the most serious warning a United States label can carry. It opens: "Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated."

It continues that minoxidil "must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent tachycardia and increased myocardial workload", and "must also usually be given with a diuretic" to prevent fluid building up. Some patients, it says, "should be hospitalized when minoxidil is first administered". Elsewhere the same label reports pericardial effusion "in about 3% of treated patients not on dialysis, especially those with inadequate or compromised renal function".

Two honest qualifications, because this is the point where hair-loss writing usually goes wrong in one direction or the other. First: that warning describes people being treated for severe hypertension, under a regime the label itself specifies. Second: nobody reading this page is in a position to know how much of it carries across to off-label use for hair — and neither are we. That uncertainty is the argument for a prescriber, not against one.

Why anyone takes the tablet for hair at all

Because the hair effect is not subtle. The tablet's adverse-reactions section reports that "elongation, thickening, and enhanced pigmentation of fine body hair are seen in about 80% of patients taking minoxidil tablets", developing "within 3 to 6 weeks after starting therapy", first "on the temples, between the eyebrows, between the hairline and the eyebrows, or in the side-burn area of the upper lateral cheek, later extending to the back, arms, legs, and scalp".

Read as a hair-loss claim, that sounds extraordinary. Read as what it is — a warning about hair arriving all over a body being treated for blood pressure — it is also a description of the main problem with the approach. The drug does not know where you wanted the hair.

The label is equally clear about what happens afterwards: "Upon discontinuation of minoxidil, new hair growth stops, but 1 to 6 months may be required for restoration to pretreatment appearance."

What genuinely differs, in plain terms

• Regulatory status. Topical: approved for hair regrowth in men. Oral: approved for hypertension, explicitly not approved for hair growth.
• Who decides. Topical: you, with a carton in your hand and a list of exclusions printed on it. Oral: a prescriber, making a judgement about your heart, kidneys and blood pressure.
• What the warnings are about. Topical: a six-item "stop use and ask a doctor" list, mostly about signals that the drug is acting beyond your scalp. Oral: a boxed warning about the pericardium and angina, plus fluid retention serious enough to require another drug alongside it.
• Where the hair appears. Topical: where it was put, with facial hair on the stop-use list as a known escape. Oral: everywhere, in most people, within weeks.
• What evidence exists. Topical: a self-reported trial paragraph printed on the carton itself. Oral: no approved label evidence for hair at all.

The comparison people actually want, and why it is not here

The question behind "oral versus topical" is usually "which works better". There is no honest way for this site to answer it. One side of the comparison has a trial paragraph on the box, in a narrow population, self-reported. The other side has no approved hair evidence whatsoever, and everything written about it comes from studies or clinics we did not read at source for this page. Putting those two on one axis and drawing a conclusion would be inventing a result.

What we can say is that the decision is not symmetrical. Choosing the bottle is a purchase; choosing the tablet is a medical decision, one that involves a drug whose own label says it must be given under close supervision when used for its approved purpose. Anyone offering the second as casually as the first is telling you something about themselves.

Before either conversation

The over-the-counter carton excludes more people than most readers realise. It says not to use it if your hair loss "is sudden and/or patchy", if "you do not know the reason for your hair loss", if you have "no family history of hair loss", or if your scalp is "red, inflamed, infected, irritated, or painful" — and to ask a doctor before use if "you have heart disease". Those exclusions exist because several kinds of hair loss look alike from the outside and need a diagnosis, not a product.

If you want the whole picture first, start with what minoxidil is and what its label claims. If your question is really about risk rather than route, the safety question is taken apart here.